Physician profile
Ray D Kelley
NPI 1780654137
$8,789.30
in general payments reported to CMS, 2019-2025
55 companies · $912 in 2025
The $912 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,109 · 2020: $741 · 2021: $1,485 · 2022: $1,396 · 2023: $1,035 · 2024: $1,112 · 2025: $912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,058.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,627.75 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $813.48 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $570.46 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $561.72 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $532.46 | 2019-2025 | Repatha, Prolia, Evenity |
| Astellas Pharma US INC | $526.78 | 2019-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $431.59 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $416.16 | 2019-2025 | |
| Allergan, INC. | $387.64 | 2019-2020 | |
| Lilly USA, LLC | $385.46 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $214.79 | 2019-2023 | Delstrigo, Dificid |
| Sanofi-Aventis U.S. LLC | $192.37 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $158.90 | 2022-2024 | |
| Mylan Specialty L.P. | $127.83 | 2019-2023 | Yupelri |
| Amarin Pharma, INC. | $124.70 | 2020-2021 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.